Kmedi Pharma Private Limited
About Kmedi Pharma Private Limited
Data last updated:
Kmedi Pharma Private Limited is a private limited company based in Nagpur, Maharashtra, India. It was incorporated on 18 January 2024.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U47721MH2024PTC417497.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ameya Sameer Kulkarni and Vaishali Sameer Kulkarni.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nagpur, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.97 Lakh. For the same year it recorded a net loss of ₹3.48 Lakh (net margin -43.7%) and EBITDA of -₹3.47 Lakh (EBITDA margin -43.5%).
Company details
Contact details
Kmedi Pharma Private Limited's registered office is in Nagpur, Maharashtra.
- Registered AddressPlot No 206/8 Gpo Square, Civil Lines, Nagpur, Maharashtra, India – 440001
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kmedi Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Kmedi Pharma Private Limited, buy the company report.
Financials of Kmedi Pharma Private Limited
FY 2025 filings availableKmedi Pharma Private Limited reported revenue of ₹7.97 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹3.47 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹3.48 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -43.5% | |
| Net Profit Margin | -43.7% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Kmedi Pharma Private Limited, buy the company report.
Board of directors of Kmedi Pharma Private Limited
Kmedi Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ameya Sameer Kulkarni | Director | 18 Jan 2024 | 2 Years 9 Months | Current |
| Vaishali Sameer Kulkarni | Director | 18 Jan 2024 | 2 Years 9 Months | Current |
Peer comparison
Kmedi Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| MNDH Healthcare Private Limited | ₹8.03 Lakh (FY 2024) | Malegaon, Maharashtra, India | ||||
| Vijaypath Merchants Private Limited | ₹8.01 Lakh (FY 2025) | 2.0% | Kolkata, West Bengal, India | |||
| Sumojay Electronics Private Limited | ₹8.01 Lakh (FY 2025) | 105.0% | New Delhi, Delhi, India | |||
| Aurimed Pharmaceutical Private Limited | ₹7.99 Lakh (FY 2025) | Kalyan, Maharashtra, India | ||||
| Manjhi Mandipur Fed Farmers Producer Company Limited | ₹7.98 Lakh (FY 2024) | Chapra, Bihar, India | ||||
| Kmedi Pharma Private Limitedthis company | ₹7.97 Lakh (FY 2025) | -₹3.48 Lakh | -43.7% | Nagpur, Maharashtra, India | ||
| Rse Solar Energy Private Limited | ₹7.97 Lakh (FY 2024) | Ballabgarh, Haryana, India | ||||
| Sarwalaukik Exim (OPC) Private Limited | ₹7.97 Lakh (FY 2024) | Sonbersa, Bihar, India | ||||
| Nu XP Lifesciences Private Limited | ₹7.97 Lakh (FY 2025) | Thane, Maharashtra, India | ||||
| Orion Lifecare Private Limited | ₹7.96 Lakh (FY 2024) | 51.0% | New Delhi, Delhi, India | |||
| Ebsir Corporation Private Limited | ₹7.93 Lakh (FY 2025) | -84.0% | Kunnathunad, Kerala, India |
To see the full peer comparison of Kmedi Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kmedi Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kmedi Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Kmedi Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Kmedi Pharma Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Ameya Sameer Kulkarni was appointed as Director on 18 Jan 2024.
Frequently asked questions
Kmedi Pharma is an active private limited company based in Nagpur, Maharashtra, India. It was incorporated on 18 January 2024 (2+ years old) and is registered under CIN U47721MH2024PTC417497.
Kmedi Pharma has 2 current directors:
- Ameya Sameer Kulkarni - Director
- Vaishali Sameer Kulkarni - Director
The latest financial statements of Kmedi Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Kmedi Pharma is U47721MH2024PTC417497. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kmedi Pharma was incorporated on 18 January 2024, making it 2+ years old. It is registered with the Registrar of Companies, Nagpur.
The peers of Kmedi Pharma by revenue are MNDH Healthcare Private Limited, Vijaypath Merchants Private Limited, Sumojay Electronics Private Limited, Aurimed Pharmaceutical Private Limited, Manjhi Mandipur Fed Farmers Producer Company Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Ameya Sameer Kulkarni was appointed as Director on 18 Jan 2024. Vaishali Sameer Kulkarni was appointed as Director on 18 Jan 2024.
The registered office of Kmedi Pharma is at Plot No 2068 Gpo Square, Civil Lines, Nagpur, Maharashtra, India – 440001.
Kmedi Pharma can be reached at its registered office: Plot No 2068 Gpo Square, Civil Lines, Nagpur, Maharashtra, India – 440001.
Kmedi Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Nagpur.